| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |